Below are the most recent publications written about "Prostate-Specific Antigen" by people in Profiles.
-
Finati M, Stephens A, Cirulli GO, Chiarelli G, Tinsley S, Morrison C, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Busetto GM, Rogers C, Carrieri G, Abdollah F. Association of race and area of deprivation index with prostate cancer incidence and lethality: results from a contemporary North American cohort. JNCI Cancer Spectr. 2024 Nov 01; 8(6).
-
Finati M, Morrison C, Stephens A, Chiarelli G, Cirulli GO, Tinsley S, Davis M, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Busetto GM, Bettocchi C, Rogers C, Carrieri G, Abdollah F. Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts. Prostate. 2025 Jan; 85(1):82-89.
-
Timilsina SS, Li X. A paper-in-polymer-pond (PiPP) hybrid microfluidic microplate for multiplexed ultrasensitive detection of cancer biomarkers. Lab Chip. 2024 Oct 22; 24(21):4962-4973.
-
Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Corsi N, Williams E, Affas R, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis. J Urol. 2024 Oct; 212(4):560-570.
-
Finati M, Davis M, Stephens A, Chiarelli G, Cirulli GO, Morrison C, Affas R, Sood A, Buffi N, Lughezzani G, Briganti A, Montorsi F, Carrieri G, Rogers C, Vickers AJ, Abdollah F. The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort. Eur Urol Oncol. 2024 Dec; 7(6):1535-1542.
-
Garraway IP, Carlsson SV, Nyame YA, Vassy JL, Chilov M, Fleming M, Frencher SK, George DJ, Kibel AS, King SA, Kittles R, Mahal BA, Pettaway CA, Rebbeck T, Rose B, Vince R, Winn RA, Yamoah K, Oh WK. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States. NEJM Evid. 2024 May; 3(5):EVIDoa2300289.
-
Chiarelli G, Davis M, Stephens A, Cirulli GO, Finati M, Corsi NJ, Sood A, Tinsley S, Carrieri G, Briganti A, Montorsi F, Lughezzani G, Buffi N, Rogers C, Abdollah F. Comparison of patient background between a real-world North American cohort and the G?teborg-2 trial. Int J Urol. 2024 May; 31(5):562-567.
-
Noriega Landa E, Quaye GE, Su X, Badmos S, Holbrook KL, Polascik TJ, Adams ES, Deivasigamani S, Gao Q, Annabi MH, Habib A, Lee WY. Urinary fatty acid biomarkers for prostate cancer detection. PLoS One. 2024; 19(2):e0297615.
-
Dalela D, Corsi NJ, Bronkema C, Sood A, Arora S, Majdalany SE, Butaney M, Jamil M, Li P, Palma-Zamora I, Rakic N, Kovacevic N, Jeong W, Menon M, Rogers CG, Schonberg MA, Abdollah F. Prostate Specific Antigen Screening on a Nationwide Level: Featuring the Contribution of Race and Life Expectancy in Decision Making. Clin Genitourin Cancer. 2024 04; 22(2):269-280.e2.
-
Mistry NA, Sun Z, Sweis J, McCall C, Marshall N, Ofori B, Hollowell CMP, Kittles RA, Schaeffer EM, Abern M, Gann P, Murphy AB. Development and Validation of a Prostate Biopsy Risk Calculator in Black Men. J Urol. 2024 Feb; 211(2):223-233.